Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Trevo 2000: Results of a Large Real-World Registry for Stent Retriever for Acute Ischemic Stroke

MJ. Binning, B. Bartolini, B. Baxter, R. Budzik, J. English, R. Gupta, H. Hedayat, A. Krajina, D. Liebeskind, RG. Nogueira, R. Shields, E. Veznedaroglu,

. 2018 ; 7 (24) : e010867. [pub] 20181218

Language English Country Great Britain

Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19045085

Background Recent randomized controlled trials show benefit of thrombectomy for large vessel occlusion in stroke. Real-world data aid in assessing reproducibility of outcomes outside of clinical trials. The Trevo Retriever Registry is a multicenter, international, prospective study designed to assess outcomes in a large cohort of patients. Methods and Results The Trevo Registry is a prospective database of patients with large vessel occlusion treated with the Trevo device as the first device. The primary end point is revascularization based on modified Thrombolysis in Cerebral Infarction score and secondary end points include 90-day modified Rankin Scale, 90-day mortality, neurological deterioration at 24 hours, and device/procedure related adverse events. Year 2008 patients were enrolled at 76 centers in 12 countries. Median admission National Institutes of Health Stroke Scale was 16 (interquartile range, 11-20). Occlusion sites were internal carotid artery (17.8%), middle cerebral artery (73.5%), posterior circulation (7.1%), and distal vascular locations (1.6%). A modified Thrombolysis in Cerebral Infarction 2b or 3 was achieved in 92.8% (95% CI, 91.6, 93.9) of procedures, with 55.3% (95% CI, 53.1, 57.5) of patients achieving modified Rankin Scale ≤2 at 3 months. Patients meeting revised 2015 American Heart Association criteria for thrombectomy had a 59.7% (95% CI , 56.0; 63.4) modified Rankin Scale 0 to 2 at 3 months, whereas 51.4% treated outside of American Heart Association criteria had modified Rankin Scale 0 to 2. 51.4% (95% CI , 49.6, 55.4). Symptomatic intracranial hemorrhage rate was 1.7% (95% CI , 1.2, 2.4). Conclusions The Trevo Retriever Registry represents real-world data with stent retriever. The registry demonstrates similar reperfusion rates and outcomes in the community compared with rigorous centrally adjudicated clinical trials. Future subgroup analysis of this cohort will assist in identifying areas of future research. Clinical Trial Registration URL : https://www.clinicaltrials.gov . Unique identifier: NCT 02040259.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045085
003      
CZ-PrNML
005      
20200113081713.0
007      
ta
008      
200109s2018 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1161/JAHA.118.010867 $2 doi
035    __
$a (PubMed)30561262
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Binning, Mandy J $u 1 Department of Neurosciences Drexel Neurosciences Institute Philadelphia PA.
245    10
$a Trevo 2000: Results of a Large Real-World Registry for Stent Retriever for Acute Ischemic Stroke / $c MJ. Binning, B. Bartolini, B. Baxter, R. Budzik, J. English, R. Gupta, H. Hedayat, A. Krajina, D. Liebeskind, RG. Nogueira, R. Shields, E. Veznedaroglu,
520    9_
$a Background Recent randomized controlled trials show benefit of thrombectomy for large vessel occlusion in stroke. Real-world data aid in assessing reproducibility of outcomes outside of clinical trials. The Trevo Retriever Registry is a multicenter, international, prospective study designed to assess outcomes in a large cohort of patients. Methods and Results The Trevo Registry is a prospective database of patients with large vessel occlusion treated with the Trevo device as the first device. The primary end point is revascularization based on modified Thrombolysis in Cerebral Infarction score and secondary end points include 90-day modified Rankin Scale, 90-day mortality, neurological deterioration at 24 hours, and device/procedure related adverse events. Year 2008 patients were enrolled at 76 centers in 12 countries. Median admission National Institutes of Health Stroke Scale was 16 (interquartile range, 11-20). Occlusion sites were internal carotid artery (17.8%), middle cerebral artery (73.5%), posterior circulation (7.1%), and distal vascular locations (1.6%). A modified Thrombolysis in Cerebral Infarction 2b or 3 was achieved in 92.8% (95% CI, 91.6, 93.9) of procedures, with 55.3% (95% CI, 53.1, 57.5) of patients achieving modified Rankin Scale ≤2 at 3 months. Patients meeting revised 2015 American Heart Association criteria for thrombectomy had a 59.7% (95% CI , 56.0; 63.4) modified Rankin Scale 0 to 2 at 3 months, whereas 51.4% treated outside of American Heart Association criteria had modified Rankin Scale 0 to 2. 51.4% (95% CI , 49.6, 55.4). Symptomatic intracranial hemorrhage rate was 1.7% (95% CI , 1.2, 2.4). Conclusions The Trevo Retriever Registry represents real-world data with stent retriever. The registry demonstrates similar reperfusion rates and outcomes in the community compared with rigorous centrally adjudicated clinical trials. Future subgroup analysis of this cohort will assist in identifying areas of future research. Clinical Trial Registration URL : https://www.clinicaltrials.gov . Unique identifier: NCT 02040259.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ischemie mozku $x diagnóza $x mortalita $x patofyziologie $x terapie $7 D002545
650    _2
$a databáze faktografické $7 D016208
650    _2
$a posuzování pracovní neschopnosti $7 D004185
650    _2
$a endovaskulární výkony $x škodlivé účinky $x přístrojové vybavení $x mortalita $7 D057510
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a protézy - design $7 D011474
650    _2
$a obnova funkce $7 D020127
650    _2
$a registrace $7 D012042
650    _2
$a rizikové faktory $7 D012307
650    12
$a stenty $7 D015607
650    _2
$a cévní mozková příhoda $x diagnóza $x mortalita $x patofyziologie $x terapie $7 D020521
650    _2
$a trombektomie $x škodlivé účinky $x přístrojové vybavení $x mortalita $7 D017131
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bartolini, Bruno $u 2 Department of Interventional Radiology La Pitié Salpétrière Paris France.
700    1_
$a Baxter, Blaise $u 3 Department of Radiology Erlanger Hospital Chattanooga TN.
700    1_
$a Budzik, Ronald $u 4 Department of Interventional Neuroradiology Riverside Methodist Hospital/Ohio Health Research Institute Columbus OH.
700    1_
$a English, Joey $u 5 Department of Neurology California Pacific Medical Center San Francisco CA.
700    1_
$a Gupta, Rishi $u 6 Department of Neurosciences Wellstar Health System Atlanta GA.
700    1_
$a Hedayat, Hirad $u 1 Department of Neurosciences Drexel Neurosciences Institute Philadelphia PA.
700    1_
$a Krajina, Antonin $u 7 Department of Radiology University Hospital Hradec Kralove Czech Republic.
700    1_
$a Liebeskind, David $u 8 Department of Neurology UCLA Los Angeles CA.
700    1_
$a Nogueira, Raul G $u 9 Department of Neurology Grady Memorial Hospital Atlanta GA.
700    1_
$a Shields, Ryan $u 10 Department of Neurovascular Intervention Stryker Neurovascular Fremont CA.
700    1_
$a Veznedaroglu, Erol $u 1 Department of Neurosciences Drexel Neurosciences Institute Philadelphia PA.
773    0_
$w MED00188127 $t Journal of the American Heart Association $x 2047-9980 $g Roč. 7, č. 24 (2018), s. e010867
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30561262 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113082045 $b ABA008
999    __
$a ok $b bmc $g 1483354 $s 1083758
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 7 $c 24 $d e010867 $e 20181218 $i 2047-9980 $m Journal of the American Heart Association $n J Am Heart Assoc $x MED00188127
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Archiving options